EGFR Inhibitors for Neoadjuvant and Adjuvant Therapy of NSCLC

• Hoofdauteur: Fabio Villa (Auteur)
• Formaat: Boek
• Gepubliceerd in: Journal of Surgery and Surgical Research - Peertechz Publications, 2015-12-17.
• Onderwerpen: Perspective Study
• Online toegang: Connect to this object online.

<p>5-year survival rates of Non-Small Cell Lung Cancer (NSCLC) remain unsatisfactory after surgery with curative intent and disease recurrences, including distant metastases, are frequent. Only a minority of this heterogeneous disease is positive for EGFR mutations and suitable for Tyrosine Ki...